Deals

Feb 2018
has divested the global rights to LEUKINE® and associated manufacturing assets to
Dec 2017
has been acquired by
Dec 2017
has been acquired by
an IPG company
Nov 2017
has been acquired by
Oct 2017
has invested in
Oct 2017
has been acquired by
Jul 2017
has received investment from
Jun 2017
has been acquired by
Jun 2017
has received investment from
May 2017
has signed a definitive merger agreement with
May 2017
has acquired
Apr 2017
an Accel-KKR portfolio company
has acquired
Mar 2017
has been acquired by
Mar 2017
has been acquired by
Dec 2016
has been acquired by
an Accel-KKR-backed company